Peter M. Hecht, Chief Executive Officer at Cyclerion Therapeutics, Inc. (CYCN), bought 1,096,002 shares at $2.53 ($2.7M) on 2021-05-05, disclosed to the SEC on 2021-05-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.29 | 300,000 | $687K | 25.4% |
| 2 | $2.53 | 398,001 | $1.0M | 37.3% |
| 3 | $2.53 | 398,001 | $1.0M | 37.3% |
| Total | $2.46 avg | 1,096,002 | $2.7M | 100% |
| Filing → |
| IRWD | SELL | 2019-01-25 | $1.1M | — | Filing → |
| IRWD | SELL | 2017-12-08 | $1.7M | — | Filing → |
| IRWD | SELL | 2017-01-13 | $1.6M | — | Filing → |